A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity

NCT06974851 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Bstructive Sleep Apnea (OSA) and Obesity

Interventions

DRUG: HRS9531
DRUG: HRS9531placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.